[Predictable, desirable and undesirable effects of the diuretic treatment].
D001692:Biological Transport; D002740:Chlorothiazide / Q000627:therapeutic use; D002752:Chlorthalidone / Q000627:therapeutic use; D004231:Diuresis; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use*; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy; D007010:Hyponatremia / Q000139:chemically induced; D009318:Natriuresis; D011188:Potassium / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D014223:Triamterene / Q000627:therapeutic use
D004232:Diuretics; D002740:Chlorothiazide; D005665:Furosemide; D012964:Sodium; D004976:Ethacrynic Acid; D002752:Chlorthalidone; D011188:Potassium; D014223:Triamterene
Effets prévisibles, désirables et indésirables des traitements diurétiques.